Literature DB >> 7093584

Benztropine-induced prolongation of responses to vasodilator nerve stimulation in the canine paw pad.

C Bell.   

Abstract

After blockade of noradrenergic transmission with guanethidine in anaesthetized dogs, stimulation of the peripheral end of the cut tibial nerve (1 Hz, 10 pulses) produces a vasodilator response which is localized to the circulation of the paw pads. The time course of the response is considerably prolonged after systemic administration of the dopamine-uptake blocking drug, benztropine (1 mg/kg). This effect is not due to inhibition of Uptake 1, as benztropine, unlike desmethylimipramine, does not prolong responses to noradrenergic vasoconstrictor nerve stimulation. The results support previous evidence suggesting that the dilator response to tibial nerve stimulation involves neural release of dopamine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093584      PMCID: PMC2071783          DOI: 10.1111/j.1476-5381.1982.tb09211.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Proceedings: Vasodilatation in the canine paw pad evoked by brain stimulation or local cooling.

Authors:  C Bell; W J Lang
Journal:  J Physiol       Date:  1974-09       Impact factor: 5.182

2.  Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.

Authors:  A S Horn; J T Coyle; S H Snyder
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

3.  Dopamine-containing axons supplying the arterio-venous anastomoses of the canine paw pad.

Authors:  C Bell; W J Lang; F Laska
Journal:  J Neurochem       Date:  1978-11       Impact factor: 5.372

4.  Vascular dopamine receptors in the canine hindlimb.

Authors:  C Bell; E L Conway; W J Lang; R Padanyi
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

5.  Involvement of uptake2 in the termination of activity of neurogenic noradrenaline in the rat isolated atrium.

Authors:  C Bell; B Grabsch
Journal:  J Physiol       Date:  1976-01       Impact factor: 5.182

6.  Involvement of uptake1 and uptake2 in terminating the cardiovascular activity of noradrenaline in normotensive and genetically hypertensive rats.

Authors:  C Bell; R Kushinsky
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

7.  Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

Authors:  B K Koe
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

8.  Evidence for dopaminergic vasodilator innervation of the canine paw pad.

Authors:  C Bell; W J Lang
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

  8 in total
  3 in total

1.  Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

2.  Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool.

Authors:  P Soares-da-Silva; R Davidson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

3.  Dopamine released from nerve terminals activates prejunctional dopamine receptors in dog mesenteric arterial vessels.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.